PeptideWellness
Take the quiz
§ By goal
§ Most read
Featured · field guide
The 2026 GLP-1 telehealth field guide.

Where the category stands in May 2026 — what's available, who to trust, what costs what. 22-min read, medically reviewed.

Read the guide
§ The providers
Who sells what — and who to trust.

An independent overview of the compounded-GLP-1 telehealth market and the providers we cover — market size, what the FDA changed, and an honest read on each.

View the provider overviewAll 17 reviews
§ Learn
The educational layer, in progress.

Primers for newcomers and deep dives for the curious. The foundation articles are published; more are in the pipeline.

View all Learn articles
§ Interactive tools
60-second quiz PeptideMatch Start here Answer four questions, get a goal-matched protocol and provider. The record GLP-1 price history Every price change we have recorded, with the figure before and after it. Overview All tools The full tools page — quiz, the Index, its history, and how we build them. Method How we measure a price What counts as the price, where we read it, and how often it is re-checked.
Free to use Medically reviewed methodology How we build our tools
PeptideWellness Index
The GLP-1 Price Index

What compounded and branded semaglutide and tirzepatide actually cost, from each provider's own published pricing.

See the full index
§ About · Team

Our team

Last updated: September 2026

PeptideWellness is written and edited by a small editorial team focused on one category: peptide therapy and the providers that prescribe it. Every contributor works to the same standards — independence, sourced claims, and acknowledged tradeoffs — set out in our editorial policy and methodology.

How the team is structured

Editorial direction is set by an editor-in-chief. Writers cover the compounds and providers; a separate editor reviews each draft against its source list before publication. Clinical content is checked by a licensed medical reviewer with specialty training matched to the topic.

Named authors & reviewers

We attach a real, named byline to a piece only when the person behind it has agreed to stand behind it and is verifiable in a public registry — we'd rather leave a byline slot empty than fill it with a name no one can check. Our editorial board is now being seated:

  • Ksenia Petrushkina, PA-C, MPAS — medical reviewer for clinical and educational content (peptides, hormones, metabolic and longevity medicine). Board-certified physician assistant, licensed in Florida.
  • David Bonfa — compounding & industry advisor, co-founder of CRE8 Pharmacy, a 503A compounding pharmacy, and president of 3AD Consulting Group. Reviews our compounding and regulatory coverage for industry accuracy: how compounded medications are prepared, handled, stored and quality-controlled, and how 503A and 503B pharmacies operate.

Full profiles, with credentials, verifiable identifiers, and the roles and companies each contributor is affiliated with, live on our authors & medical review page; every byline on the site links there.

What every contributor works to

No payment for coverage, placement, or scoring, no invented customer experiences, and no claim that isn't sourced or labeled. Provider coverage is decided by editorial judgment alone. The full set of standards is in our editorial policy; how we source and verify is in our methodology.

Get in touch

Story tips, corrections, and questions for the editorial team go to editorial@peptidewellnessusa.com. More ways to reach us are on our contact page.

Editorial note: this page is for informational purposes and does not constitute medical advice. Always consult a licensed healthcare provider familiar with your medical history.

Authors & reviewers Our methodology